A national survey of US physicians has found that pediatricians are more likely to remain in the communities in which they practice.
Contemporary Pediatrics week in review: sNDA acceptance for roflumilast, pz-cel Priority Review, and more
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Food Insecurity and the Dangers of Infant Formula Dilution
Underused antivirals in pediatric influenza treatment
In the almost 10 years of data collected by the research team, nearly 1.5 million antiviral medications were dispensed to pediatric patients, and oseltamivir accounted for 99.8% of those prescriptions.
Demystifying Infant Formula
FDA warns of serious potential reaction to levetiracetam and clobazam
The reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), can start as a rash but can progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
FDA accepts sNDA for roflumilast cream 0.15% to treat atopic dermatitis
The FDA has accepted a supplemental New Drug Application (sNDA) for roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) in children aged 6 years and up.
2 Clarke Drive Cranbury, NJ 08512